GALMED PHARMACEUTICALS LTD. Increase (Decrease) in Accounts Payable, Trade
GALMED PHARMACEUTICALS LTD. (GLMD) reported Increase (Decrease) in Accounts Payable, Trade of -$114.00 thousand for the 6-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $329.00K.
- GALMED PHARMACEUTICALS LTD. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $305.00K, a 119.42% increase year-over-year.
- GALMED PHARMACEUTICALS LTD. increase (decrease) in accounts payable, trade for the quarter ending 2024-12-31 was -$34.00K.
- GALMED PHARMACEUTICALS LTD. increase (decrease) in accounts payable, trade for the quarter ending 2024-09-30 was $139.00K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$114.00K 6-K · filed 2026-09-02 | |||
| 2025-12-31 | $329.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $634.00K derived: sum of 2 quarters · filed 2026-03-31 | $695.00K 20-F · filed 2026-03-31 | |
| 2025-09-30 | $305.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | $366.00K 6-K · filed 2025-11-26 | ||
| 2025-06-30 | $61.00K 6-K · filed 2026-09-02 | |||
| 2024-12-31 | -$34.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $105.00K derived: sum of 2 quarters · filed 2026-03-31 | -$571.00K 20-F · filed 2026-03-31 | |
| 2024-09-30 | $139.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | -$537.00K 6-K · filed 2025-11-26 | ||
| 2024-06-30 | -$676.00K 6-K · filed 2025-08-28 | |||
| 2023-12-31 | -$681.00K 20-F · filed 2026-03-31 | |||
| 2023-06-30 | -$420.00K 6-K · filed 2024-08-28 | |||
| 2022-12-31 | -$2.31M 20-F · filed 2025-04-02 | |||
| 2022-06-30 | -$2.78M 6-K · filed 2023-08-09 | |||
| 2021-12-31 | -$2.17M 20-F · filed 2024-04-04 | |||
| 2021-06-30 | -$1.42M 6-K · filed 2022-08-04 | |||
| 2020-12-31 | $1.05M 20-F · filed 2023-03-29 | |||
| 2020-06-30 | -$2.12M 6-K · filed 2021-08-05 | |||
| 2019-12-31 | $4.18M 20-F · filed 2022-05-02 | |||
| 2019-06-30 | $764.00K 6-K · filed 2020-08-06 | |||
| 2018-12-31 | -$462.00K 20-F · filed 2021-03-18 | |||
| 2018-06-30 | $70.00K 6-K · filed 2019-08-05 | |||
| 2017-12-31 | -$846.00K 20-F · filed 2020-03-12 | |||
| 2017-06-30 | -$757.00K 6-K · filed 2018-08-02 | |||
| 2016-12-31 | $863.00K 20-F · filed 2019-03-13 | |||
| 2016-06-30 | $706.00K 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $1.38M 20-F · filed 2018-03-13 | |||
| 2015-06-30 | $354.00K 6-K · filed 2017-06-23 | |||
| 2014-12-31 | -$480.00K 20-F · filed 2017-03-23 | |||
| 2013-12-31 | $954.00K 20-F · filed 2016-03-22 | |||
| 2012-12-31 | -$89.00K 20-F · filed 2015-03-31 |